Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Marc Mathias

Concepts (118)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Macular Degeneration
15
2026
196
2.340
Why?
Geographic Atrophy
8
2025
103
1.310
Why?
Visual Acuity
11
2026
497
1.030
Why?
Wet Macular Degeneration
5
2026
63
0.860
Why?
Tomography, Optical Coherence
7
2025
277
0.500
Why?
Retinal Drusen
3
2021
31
0.490
Why?
Eye Infections, Bacterial
2
2015
46
0.450
Why?
Registries
6
2025
2382
0.410
Why?
Fluorescein Angiography
5
2025
195
0.370
Why?
Orbital Cellulitis
1
2012
17
0.350
Why?
Complement Activation
3
2025
412
0.340
Why?
Endophthalmitis
3
2017
46
0.330
Why?
Complement Factor B
2
2022
106
0.310
Why?
Choroid
3
2025
80
0.290
Why?
Methicillin-Resistant Staphylococcus aureus
1
2012
253
0.280
Why?
Staphylococcal Infections
1
2012
396
0.260
Why?
Choroid Diseases
2
2023
10
0.230
Why?
Fovea Centralis
1
2025
24
0.230
Why?
Chemokine CCL5
2
2023
40
0.220
Why?
Vitreous Body
2
2015
118
0.200
Why?
Diseases in Twins
1
2024
114
0.200
Why?
Twins
1
2024
156
0.200
Why?
Retinal Degeneration
1
2023
40
0.190
Why?
Retinopathy of Prematurity
1
2024
183
0.180
Why?
Vitrectomy
3
2025
74
0.180
Why?
Complement System Proteins
1
2025
324
0.180
Why?
Aged, 80 and over
9
2026
8351
0.180
Why?
Birth Weight
1
2024
521
0.170
Why?
Follow-Up Studies
7
2026
5397
0.170
Why?
National Eye Institute (U.S.)
1
2020
6
0.160
Why?
Neurodegenerative Diseases
1
2022
147
0.150
Why?
Retinal Neovascularization
1
2019
29
0.150
Why?
Surveys and Questionnaires
5
2026
6050
0.150
Why?
Complement Membrane Attack Complex
1
2019
38
0.150
Why?
Aged
14
2026
26251
0.150
Why?
Complement C3a
1
2019
40
0.150
Why?
Estrogen Replacement Therapy
1
2019
144
0.140
Why?
Choroidal Neovascularization
1
2019
57
0.140
Why?
Internet
1
2023
656
0.140
Why?
Female
20
2026
79080
0.130
Why?
Anterior Eye Segment
1
2017
10
0.130
Why?
Humans
27
2026
145625
0.120
Why?
Strabismus
1
2017
71
0.120
Why?
Automobile Driving
1
2018
156
0.120
Why?
Male
17
2026
73014
0.120
Why?
Ophthalmologic Surgical Procedures
1
2017
91
0.120
Why?
Retinal Vein Occlusion
1
2015
14
0.110
Why?
Needles
1
2015
61
0.110
Why?
Retrospective Studies
8
2025
17291
0.110
Why?
Biopsy, Needle
1
2015
182
0.110
Why?
Self Report
1
2018
869
0.100
Why?
Sickness Impact Profile
2
2026
67
0.100
Why?
Fibrin
1
2014
84
0.100
Why?
Ischemia
1
2017
421
0.100
Why?
Angiogenesis Inhibitors
1
2015
238
0.100
Why?
Research Design
1
2019
1139
0.090
Why?
Retina
1
2015
330
0.090
Why?
Eyelid Diseases
1
2012
26
0.090
Why?
Diabetic Retinopathy
1
2014
211
0.090
Why?
Ocular Motility Disorders
1
2012
42
0.090
Why?
Cross-Sectional Studies
4
2025
5875
0.080
Why?
Edema
1
2012
129
0.080
Why?
Quality of Life
4
2026
3187
0.080
Why?
Biomarkers
4
2023
4329
0.080
Why?
Middle Aged
8
2026
36359
0.080
Why?
Bacteria
1
2015
766
0.070
Why?
Atrophy
2
2023
199
0.070
Why?
Antibodies, Monoclonal, Humanized
1
2015
992
0.070
Why?
Time Factors
3
2025
7079
0.070
Why?
Disease Progression
2
2026
2857
0.070
Why?
Odds Ratio
2
2019
1070
0.060
Why?
Colorado
3
2022
4588
0.060
Why?
Fundus Oculi
1
2025
89
0.060
Why?
Anti-Bacterial Agents
2
2015
1935
0.050
Why?
Risk Factors
3
2025
10840
0.050
Why?
Infant
2
2025
10093
0.050
Why?
Child, Preschool
2
2025
11888
0.050
Why?
Proportional Hazards Models
1
2026
1318
0.050
Why?
Interleukin-4
1
2023
207
0.050
Why?
Complement Factor I
1
2022
12
0.050
Why?
Phenotype
2
2022
3186
0.040
Why?
Tomography, X-Ray Computed
1
2012
2766
0.040
Why?
Postoperative Complications
1
2014
2962
0.040
Why?
Gestational Age
1
2024
989
0.040
Why?
Fibrinogen
1
2022
181
0.040
Why?
Retinal Ganglion Cells
1
2022
123
0.040
Why?
Vision Disorders
1
2022
178
0.040
Why?
Inflammation
2
2023
2915
0.040
Why?
Immunologic Factors
1
2022
244
0.040
Why?
Protective Factors
1
2019
97
0.040
Why?
Adolescent
2
2025
22451
0.040
Why?
Magnetic Resonance Imaging
1
2012
3917
0.040
Why?
C-Reactive Protein
1
2021
427
0.040
Why?
Child
2
2025
22638
0.040
Why?
Prospective Studies
2
2020
8087
0.030
Why?
Iris Diseases
1
2017
7
0.030
Why?
Anti-Inflammatory Agents
1
2021
473
0.030
Why?
Enzyme-Linked Immunosorbent Assay
1
2019
845
0.030
Why?
Sex Characteristics
1
2022
798
0.030
Why?
Mental Health
1
2022
771
0.030
Why?
Microbiological Techniques
1
2015
30
0.030
Why?
Colony Count, Microbial
1
2015
90
0.030
Why?
Multivariate Analysis
1
2019
1531
0.030
Why?
Young Adult
1
2012
14240
0.030
Why?
Intravitreal Injections
1
2015
73
0.030
Why?
Macular Edema
1
2015
49
0.030
Why?
Logistic Models
1
2019
2112
0.030
Why?
Bevacizumab
1
2015
167
0.030
Why?
Proteins
1
2020
1021
0.030
Why?
Proteomics
1
2020
1202
0.020
Why?
T-Lymphocytes
1
2022
2007
0.020
Why?
Infant, Newborn
1
2024
6449
0.020
Why?
Vascular Endothelial Growth Factor A
1
2015
543
0.020
Why?
Adult
2
2015
40821
0.020
Why?
Case-Control Studies
1
2019
3633
0.020
Why?
Cohort Studies
1
2019
6045
0.020
Why?
Models, Biological
1
2015
1758
0.020
Why?
United States
1
2020
16041
0.010
Why?
Mathias's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)